Molecular Oncology
Volume 2, Issue 4 , Pages 368-379 , December 2008

A single lysis solution for the analysis of tissue samples by different proteomic technologies

  • Pavel Gromov

      Affiliations

    • Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author at: Danish Centre for Translational Breast Cancer Research and Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark. Fax: +45 35 257 354.
    • ,
  • Julio E. Celis

      Affiliations

    • Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • ,
  • Irina Gromova

      Affiliations

    • Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • ,
  • Fritz Rank

      Affiliations

    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • Department of Pathology, the Centre of Diagnostic Investigations, Rigshospitalet, Denmark
    • ,
  • Vera Timmermans-Wielenga

      Affiliations

    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • Department of Pathology, the Centre of Diagnostic Investigations, Rigshospitalet, Denmark
    • ,
  • José M.A. Moreira

      Affiliations

    • Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
    • Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author at: Danish Centre for Translational Breast Cancer Research and Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark. Fax: +45 35 25 73 54.

Received 26 August 2008 ,Revised 17 September 2008 ,Accepted 17 September 2008.

References 

  1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198–207
  2. Ben-Kasus T, Schechter B, Sela M, Yarden Y. Cancer therapeutic antibodies come of age: targeting minimal residual disease. Mol. Oncol. 2007;1:42–54
  3. Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature. 2001;411:355–365
  4. Bodzon-Kulakowska A, Bierczynska-Krzysik A, Dylag T, Drabik A, Suder P, Noga M, et al. Methods for samples preparation in proteomic research. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007;849:1–31
  5. Carrette O, Burkhard PR, Sanchez JC, Hochstrasser DF. State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research. Nat. Protoc. 2006;1:812–823
  6. Celis JE, Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell. 2003;3:9–15
  7. Celis A, Rasmussen HH, Celis P, Basse B, Lauridsen JB, Ratz G, et al. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis. 1999;20:355–361
  8. Celis JE, Gromov P, Gromova I, Moreira JM, Cabezón T, Ambartsumian N, et al. Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. Mol. Cell. Proteomics. 2003;2:369–377
  9. Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics. 2004;3:327–344
  10. Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, et al. Towards discovery-driven translational research in breast cancer. FEBS J. 2005;272:2–15
  11. Celis JE, Moreira JM, Cabezon T, Gromov P, Friis E, Rank F, et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics. 2005;4:492–522
  12. Celis JE, Trentemølle S, Gromov P. In:  Celis JE,  Carter N,  Hunter T,  Simons K,  Small JV,  Shotton D editor. A Cell Biology. Laboratory Handbook. third ed. Gel-based proteomics: high-resolution two-dimensional gel electrophoresis of proteins. Isoelectric focusing and nonequilibrium pH gradient electrophoresis. vol. 4:San Diego: Elsevier Academic Press, Inc; 2006;p. 165–174
  13. Celis JE, Moreira JMA, Gromov P. In:  Celis JE,  Carter N,  Hunter T,  Simons K,  Small JV,  Shotton D editor. A Cell Biology. Laboratory Handbook. third ed. Determination of antibody specificity by Western blotting. vol. 4:San Diego: Elsevier Academic Press, Inc; 2006;p. 527–532
  14. Celis JE, Moreira JMA, Gromova I, Cabezón T, Gromov P, Shen T, et al. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol. Oncol. 2007;1:97–119
  15. Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, et al. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. Mol. Oncol. 2007;1:321–349
  16. Celis JE, Gromov P, Cabezon T, Moreira JM, Friis E, Jirstrom K, et al. 15-PGDH expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinomae. Mol. Cell. Proteomics. 2008;[Epub ahead of print]
  17. Chen EI, Yates JR. Cancer proteomics by quantitative shotgun proteomics. Mol. Oncol. 2007;1:144–159
  18. Cravatt BF, Simon GM, Yates JR. The biological impact of mass-spectrometry-based proteomics. Nature. 2007;450:991–1000
  19. Dominguez DC, Lopes R, Torres ML. Proteomics: clinical applications. Clin. Lab. Sci. 2007;20:245–248
  20. Dumur CI, Nasim S, Best AM, Archer KJ, Ladd AC, Mas VR, et al. Evaluation of quality-control criteria for microarray gene expression analysis. Clin. Chem. 2004;50:1994–2002
  21. Forrester S, Hung KE, Kuick R, Kucherlapati R, Haab BB. Low-volume, high-throughput sandwich immunoassays for profiling plasma proteins in mice: identification of early-stage systemic inflammation in a mouse model of intestinal cancer. Mol. Oncol. 2007;1:216–225
  22. Geho DH, Petricoin EF, Liotta LA, Araujo RP. Modeling of protein signaling networks in clinical proteomics. Cold Spring Harb. Symp. Quant. Biol. 2005;70:517–524
  23. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P. A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol. Cell. Proteomics. 2004;3:1102–1118
  24. Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4:3665–3685
  25. Gromova I, Celis JE. Protein detection in gels by silver staining: a procedure compatible with mass spectrometry. In:  Celis JE,  Carter N,  Hunter T,  Shotton D editor. Cell Biology. A Laboratory Handbook. San Diego: Academic Press, Inc; 2006;p. 219–223
  26. Haab, B.B., Dunham, M.J., Brown, P.O., 2001. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions, Genome Biol. 2, RESEARCH0004.
  27. Helbich TH, Rudas M, Haitel A, Kohlberger PD, Thurnher M, Gnant M, et al. Evaluation of needle size for breast biopsy: comparison of 14-, 16-, and 18-gauge biopsy needles. Am. J. Roentgenol. 1998;171:59–63
  28. Hober S, Uhlén M. Human protein atlas and the use of microarray technologies. Curr. Opin. Biotechnol. 2008;19:30–35
  29. Hunter T, Sefton B. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA. 1980;77:1311–1315
  30. Issaq H, Veenstra T. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques Apr. 2008;44(5):697–698700
  31. Jain KK. Innovations, challenges and future prospects of oncoproteomics. Mol. Oncol. 2008;2:153–160
  32. Jaras K, Ressine A, Nilsson E, Malm J, Marko-Vara G, Lilja H, et al. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective. Anal. Chem. 2007;79:5817–5825
  33. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 2007;1:84–96
  34. Koomen JM, Haura EB, Bepler G, Sutphen R, Remily-Wood ER, Benson K, et al. Proteomic contributions to personalized cancer care. Mol. Cell. Proteomics. 2008;[Epub ahead of print]
  35. Kruse U, Bantscheff M, Drewes G, Hopf C. Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. Mol. Cell. Proteomics. 2008;[Epub ahead of print]
  36. Li, J., Gromov, P., Gromova, I., Moreira, J.M., Timmermans-Wielenga, V., Rank, F., Wang, K., Li, S., Li, H., Wiuf, C., Yang, H., Zhang, X., Bolund, L., Celis J.E., 2008. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics in press.
  37. Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell. 2003;3:317–325
  38. Loch CM, Ramirez AB, Liu Y, Sather CL, Delrow JJ, Scholler N, et al. Use of high density antibody arrays to validate and discover cancer serum biomarkers. Mol. Oncol. 2007;1:313–320
  39. McDonald WH, Yates JR. Shotgun proteomics: integrating technologies to answer biological questions. Curr. Opin. Mol. Ther. 2003;5:302–309
  40. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975;250:4007–4021
  41. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis. 2000;21:2235–2242
  42. Rabilloud T, Luche S, Santoni V, Chevallet M. Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis. Methods Mol. Biol. 2007;355:111–119
  43. Rapkiewicz A, Espina V, Zujewski J, Lebowitz PF, Filie A, Wulfkuhle J, et al. The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology. Cancer. 2007;111:173–184
  44. Riegman PHJ, Morente MM, Betsou F, de Blasio P, Geary P. The Marble Arch International Working Group on Biobanking for Biomedical Research. Biobanking for better healthcare Mol. Oncol. 2008;2:213–222
  45. Reymond MA, Schlegel W. Proteomics in cancer. Adv. Clin. Chem. 2007;44:103–142
  46. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006;24:971–983
  47. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996;68:850–858
  48. Simpson RJ, Bernhard OK, Greening DW, Moritz RL. Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol. 2008;12:72–77
  49. Suzuki M, Tarin D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol. Oncol. 2007;1:172–180
  50. Weiss W, Görg A. Sample solubilization buffers for two-dimensional electrophoresis. Methods Mol. Biol. 2008;424:35–42
  51. Weissenstein U, Schneider MJ, Pawlak M, Cicenas J, Eppenberger-Castori S, Oroszlan P, et al. Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts. Proteomics. 2006;6:1427–1436
  52. Wingren C, Borrebaeck CA. Antibody microarrays: current status and key technological advances. OMICS. 2006;10:411–427
  53. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics. 2003;3:2085–2090

PII: S1574-7891(08)00123-3

doi: 10.1016/j.molonc.2008.09.003

Molecular Oncology
Volume 2, Issue 4 , Pages 368-379 , December 2008

Article Tools

* Image Usage & Resolution